| 英文别名 |
Iminostilbene;CARBAMAZEPINE INTERMEDIATES;5H-Dibenz[b,f]azepine;IMINOSTILBENE (BROMINE FREE);5-Azadibenzo(a,e)cycloheptatriene;Dibenz(b,f)azepine;Stilbene, 2,2'-imino-;(-)-O-FORMYL-D-MANDELOYL CHLORIDE;R-FMOC;5H-Dibenz[b,f]azepine (Iminostilbene);5H-Dibenzo[b,f]azepine;2,2'-Iminostilbense;Carbamazepine Related Compound B;dibenzazepine;Iminostilben;Minostilbene;o,o'-Iminostilbene;2,2'-Iminostilbene;2,3,6,7-Dibenzazepine;5H-Dibenz(b,f)azepine;Dibenz[b,f]azepine;5H-Dibenzo(b,f)azepine;11H-benzo[b][1]benzazepine;5H-Dibenz[b,f]azepin;(Z)-5H-Dibenzo[b,f]azepine;MLS000737549;J411KQJ8C2;5-Azadibenzo[a,e]cycloheptatriene;LCGTWRLJTMHIQZ-UHFFFAOYSA-N;dib;HMS3886O07;NS00124786;SMR000065475;AM84843;2,6,7-Dibenzazepine;CARBAMAZEPINE IMPURITY D [IP];iminostilbene; p-toluenesulfonic acid sodium salt; toluene-4-sulfonic acid sodium salt; 4-methylbenzenesulfonic acid sodium salt;W-107225;Z56754946;tert-butyl (1S,2S)-1-[[methoxy(methyl)amino]carbonyl]-2-methylbutylcarbamate;F15408;5H-dibenzo[b,f]azepine;Oxcarbazepine EP IMpurity E;;FT-0670315;CARBAMAZEPINE IMPURITY D [EP IMPURITY];MFCD00005071;Stilbene,2'-imino-;EC 205-970-0;AC-11074;5H-Dibenz[b,f]azepine, purum, >=97.0% (NT);NSC123458;CHEBI:47802;CS-W015765;NSC-123458;SCHEMBL10434951;STR04241;5H-dibenzazepine;FT-0627190;NSC 123458;SCHEMBL75288;UNII-J411KQJ8C2;RP-9989;EN300-176476;Oprea1_371695;s4973;2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene;AKOS015894918;2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,9,11,13-heptaene;HMS2769I10;CCG-266525;HY-N7064;5H-Dibenz[b,f]azepine, 97%;NCGC00246953-01;CHEMBL243596;NS00000328;OXCARBAZEPINE IMPURITY E [EP IMPURITY];Q61388;256-96-2;DTXSID90871625;HMS1664F10;EINECS 205-970-0;5H-Dibenzo[b,f]azepine (Iminostilbene);I0414;Oxcarbazepine EP Impurity E;CARBAMAZEPINE IMPURITY D (IP);5H-Dibenz(b,f)azepin;DB-046759;Iminostilbene-d2;iminostilbene, 10-(13)C-labeled;DTXCID4020458;DTXCID60819276;GSI XX;CARBAMAZEPINE IMPURITY D (EP IMPURITY);OXCARBAZEPINE IMPURITY E (EP IMPURITY) |